These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 4104378

  • 41. [Current data and contribution to the study of hemolytic disease caused by feto-maternal blood incompatibility].
    Trifan N, Lupaşcu G, Trifan E.
    Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):1049-54. PubMed ID: 4135203
    [No Abstract] [Full Text] [Related]

  • 42. [Rhesus sensitization and prevention with anti-D-immunoglobulin].
    Hindemann P, Hinselmann M, Frey P.
    Gynaecologia; 1969; 167(5):276-9. PubMed ID: 4184763
    [No Abstract] [Full Text] [Related]

  • 43. [Diagnostic and therapeutic possibilities in incompatibility processes].
    Kozlowski P.
    Gynakologe; 1990 Jun; 23(3):172-7. PubMed ID: 2117563
    [No Abstract] [Full Text] [Related]

  • 44. [Experimental and clinical studies on 1st transabdominal flooding of the maternal circulation with fetal erythrocytes (new aspects of Rh sensitization)].
    Hindemann P.
    Geburtshilfe Frauenheilkd; 1966 Oct; 26(10):1359-72. PubMed ID: 4162573
    [No Abstract] [Full Text] [Related]

  • 45. Interaction between placental alkaline phosphatase and ABO system polymorphisms. Effects on the clinical manifestations of feto-maternal ABO incompatibility.
    Bottini E, Lucarelli P, Orzalesi M, Palmarino R, Di Mino M, Gloria F, Terrenato L, Spennati GF.
    Vox Sang; 1972 Oct; 23(5):413-9. PubMed ID: 4627823
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Immunoglobulins in human fetal sera at different stages of gestation.
    Toivanen P, Rossi T, Hirvonen T.
    Experientia; 1969 May 15; 25(5):527-8. PubMed ID: 4183674
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J, Gryglicka M.
    Acta Haematol Pol; 1988 May 15; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Some factors influencing Rh immunization during pregnancy.
    Cooke BR, Bradley MA, Walsh RJ.
    Med J Aust; 1965 Sep 11; 2(11):437-41. PubMed ID: 4953260
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.